Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.38 +0.26 (+23.87%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) EBITDA (2020 - 2026)

Updated

Nautilus Biotechnology (NAUT) recorded EBITDA of -$15.46 million in Q2 2026, compared with -$16.7 million a year earlier.

Analysis

Nautilus Biotechnology (NAUT) EBITDA (2020 - 2026) Analysis & Trends

On a TTM basis, Nautilus Biotechnology's EBITDA came in at -$33.71 million as of Jun 30, 2026; for FY2020, it came in at $133,965.

  • The Q2 2026 figure is the highest quarterly EBITDA since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 2.75 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 1.19 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 2.49 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 1.53 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 1.23 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 555.90 Mn
10 Nautilus Biotechnology 141.22 Mn 141.22 Mn 175,000.00 -15.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.46 Mn
Jun 30, 2025 -16.70 Mn
Mar 31, 2021 -1.57 Mn
Sep 30, 2020 25,329.00
API Access

Nautilus Biotechnology EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=NAUT&period=max&api_key=YOUR_API_KEY